The stock of Syneos Health Inc. (NASDAQ:SYNH) decreased by -$0.04 on Friday to finish at $42.59, down -0.09 percent. The last five days have seen an average of 1,025,200 shares of common stock traded. 6 times new highs were reached in the current year, with a gain of $5.91. The average number of shares traded over the last 20 days was 1,181,970, while the average volume over the last 50 days totaled 1,580,296.
SYNH stock appreciated 0.61% since last month. On 07/12/23, the company’s shares reached a one-month low of $42.24. The stock touched a high of $71.68 on 02/27/23, after rallying from a low of $22.89 in 52 weeks. The price of SYNH stock has risen by 16.11% or $5.91 this year, reaching a new high 6 times. Still, the stock price is down -40.58% from the 52-week high.
Valuation Metrics
Syneos Health Inc. (SYNH) has a trailing price-to-earnings (P/E) ratio of 61.64. Beta for the stock is 1.57. There are also a few other valuation ratios worth considering, including the trailing price-to-sales (P/S) ratio of 0.82, the price-to-book (PB) ratio of 1.26, and the price-to-cash flow ratio of 27.31.
Financial Health
For the three months ended March 30, Syneos Health Inc.’s quick ratio was 1.20, while its current ratio was 1.20, indicating its ability to pay off its debt. The company’s long-term debt to equity ratio for the quarter ending March 30 is 0.77, and the total debt to equity ratio is 0.77. As far as profitability goes, gross margin for the trailing twelve months is 22.10% percent. Syneos Health Inc.’s EBITDA margin for the year ended March 30 was 13.10%, whereas its operating margin stood at 4.00% for the same period. Based on annual data, it had gross profit of $1.25 billion and revenue of $5.39 billion.
Investors will also look at the performance of the company’s management in order to determine the potential profitability of their investment. SYNH’s return on assets (ROA) during the last 12 months has been 0.90%. There was a 5.70% return on investment (ROI) in the past year. In the meantime, the return on equity (ROE) for the last 12 months was 2.10%.
Earnings Surprise
According to Syneos Health Inc.’s quarterly financial report for the quarter that ended March 30. A higher net income was reported in the quarter under review than the previous quarter. Net income for the quarter came in at $1.37 billion, while revenues rose by 0.39% to $1.36 billion. It was predicted that Syneos Health Inc.’s quarterly earnings would be $0.75, but it ended up being $0.66, beating the consensus by 13.60%. EBITDA was $101.55 million for the quarter. At the end of Syneos Health Inc.’s most recent quarter ended March 30, its liabilities totaled 4.58 billion, while its total debt was $2.9 billion. Equity owned by shareholders amounts to $103.72 million.
Technical Picture
Here’s a quick look at Syneos Health Inc.’s (SYNH) price momentum from a technical perspective. As of 11 August, the RSI 9-day stood at 66.14%, suggesting the stock is Neutral, with a 1.98% historical volatility rate.
The stochastic %K and %D were 70.19% and 75.58% respectively, while the average true range (ATR) was 0.13. Based on the 14-day stochastic reading of 65.12%, the RSI (14) reading is 65.46%. On the 9-day MACD Oscillator, the stock is at 0.11, and the 14-day reading is at 0.13.
Analyst Ratings
Syneos Health Inc. (NASDAQ: SYNH) was downgraded by JP Morgan to a an Underweight rating in its latest research report. The stock was previously rated as a a Neutral.
What is SYNH’s price target for the next 12 months?
The current consensus forecast for the stock is between $43.00 and $43.00, with a median target price of $43.00. In analyzing these forecasts, the average price target given by analysts for Syneos Health Inc. (SYNH) is $43.00.
